- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06172842
Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease
January 22, 2024 updated by: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
From 2020 to 2023, patients with primary electrical disease (idiopathic ventricular fibrillation, long QT syndrome, Andersen-Tawil syndrome type I, Brugada syndrome, early repolarization syndrome, CPVT, and short QT syndrome) were first diagnosed at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and clinical data and echocardiographic indicators were recorded.
Follow-up is until December 30, 2025 or endpoint event occurs.
Endpoint events were defined as sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, ICD discharge events, all-cause death, heart failure and heart transplantation, which were statistically analyzed as a composite endpoint of cardiovascular analysis.
The predictors of primary electrical disease and the risk factors for adverse cardiovascular events were analyzed.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: hanlu lv
- Phone Number: 13430268178
- Email: lv-hl@163.com
Study Locations
-
-
-
Guangzhou, China
- Recruiting
- Hanlu Lv
-
Contact:
- Hanlu Lv
- Email: lv-hl@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
primary electrical disease
Description
Inclusion Criteria:
- primary electrical disease
Exclusion Criteria:
- Congenital heart disease, poor echocardiographic images, moderate or severe valvular disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
control
|
Multi-modality echocardiography
|
primary electrical disease
|
Multi-modality echocardiography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Multi-modality echocardiography
Time Frame: 2 years
|
tissue Doppler imging, speckle-tracking-strain, myocardial work, mechanical dispersion,electro-mechanical window
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2024
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
November 24, 2023
First Submitted That Met QC Criteria
December 7, 2023
First Posted (Actual)
December 15, 2023
Study Record Updates
Last Update Posted (Actual)
January 23, 2024
Last Update Submitted That Met QC Criteria
January 22, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- SYSKY-2023-1069-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multi-modality Echocardiography
-
Healthy Relationships CaliforniaRecruitingProgram ModalityUnited States
-
Healthy Relationships CaliforniaRecruitingProgram ModalityUnited States
-
Montana State UniversityRecruiting
-
Weill Medical College of Cornell UniversityCompleted
-
Patrick F Wouters, MD PhDCompletedEchocardiography, Doppler | Echocardiography, Three-Dimensional | Echocardiography, Transesophageal | Echocardiography, TransthoracicBelgium
-
University of HawaiiCompletedEducation | Echocardiography | Transthoracic Echocardiography | Medical StudentUnited States
-
Imperial College LondonCompletedEchocardiography | Preoperative PeriodUnited Kingdom
-
Children's & Women's Health Centre of British ColumbiaCompletedCardiac Echocardiography AssessmentCanada
-
Centre Hospitalier Universitaire, AmiensCompleted
-
Istituto Auxologico ItalianoMedimatic S.R.L., Genova, ItalyRecruitingEchocardiographyItaly
Clinical Trials on Echocardiography
-
Lifetech Scientific (Shenzhen) Co., Ltd.RecruitingNon-valvular Atrial Fibrillation | Embolic StrokeChina
-
Kang YanRecruiting
-
Assiut UniversityUnknownCORONARY ARTERY BYPASSEgypt
-
Assiut UniversityNot yet recruiting
-
Assiut UniversityUnknownMyocardial Infarction | Left Ventricular Dysfunction | Echocardiography 2DEgypt
-
Milton S. Hershey Medical CenterCompletedEchocardiography, Transesophageal | Ventricular Function, RightUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingBacteremia | Staphylococcus Aureus | Infective EndocarditisFrance
-
Weill Medical College of Cornell UniversityWithdrawn3D Transesophageal and Transthoracic EchocardiogramUnited States
-
London North West Healthcare NHS TrustRecruitingCoronary Artery DiseaseUnited Kingdom
-
Papworth Hospital NHS Foundation TrustUnknownChronic Thromboembolic Pulmonary Hypertension